Alzheimer's / Dementia Medications
Common brand names: Donepezil (Aricept), Rivastigmine, Memantine
One nutrient listed against this medication. The most severe is marked moderate.
At a glance
At a glance
- Phosphatidylserine + Omega-3 DHAModerate · Traditionally cited, limited evidence
Color shows how serious each listed effect is. The label beside it shows how strong the evidence is. The cards below explain each one and show its evidence.
Nutrients it can lower
Mechanism, These medications manage symptoms but do not address the underlying phospholipid membrane deficiencies in neurons. Phosphatidylserine and DHA support the structural integrity of neuronal membranes.
Common signs, Progressive cognitive decline, neuronal membrane deterioration
Vakhapova et al. (Dement Geriatr Cogn Disord, 2010; PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 20523044): phosphatidylserine with omega-3 improved some memory measures in non-demented elderly with memory complaints. That is a supplement benefit, not a depletion caused by Alzheimer's drugs.
Phosphatidylserine was used at 100 mg three times daily with DHA-rich omega-3 at 2 g or more daily; this is discussed with the neurologist.
For your next appointment
It prints or saves as a single page. Whether to add a supplement for a nutrient this medication may lower is a decision for your prescriber.
Disclosure
These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.
Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →